Corrigendum to “Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment” [Multiple Sclerosis and Related Disorders, Volume 79, November 2023, https://doi.org/10.1016/j.msard.2023.104949]

Update your browser to view ScienceDirect.

Request details:

Request ID: 8dbe5206e9e8faaa-LAX
IP: 116.62.10.13
UTC time: 2024-11-01T19:34:07+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4

View original article

MULTIPLE SCLEROSIS AND RELATED DISORDERS

Like

分享书签

0 0 0 0 0 0 0

More from this channel

Corrigendum to “Severe disease reactivation in seropositive neuromyelitis optica spectrum disorders patients after stopping eculizumab treatment” [Multiple Sclerosis and Related Disorders, Volume 79, November 2023, https://doi.org/10.1016/j.msard.2023.104949]

留言 (0)